Celleste Bio

Overview
News
Alternative Ingredients?
Product stageSegments
Ideation
?
Cocoa-free chocolates
?

Founded in 2022, Celleste Bio is an Israel-based spin-off of Ginkgo Bioworks (a leading platform for cell programming and biosecurity) focused on the production of cocoa ingredients using cell culture methods from naturally occurring cocoa cells without genetic modification or manipulation.

As of November 2022, the company's technology was still in development, and it was looking to move to a production facility once it reached 1,000 liters of biomass production at the lab scale.

Funding and financials

In November 2022, Celleste Bio was launched with a seed funding round for an undisclosed amount.

HQ location:
Misgav ISR
Founded year:
2022
Employees:
-
IPO status:
Private
Total funding:
USD 4.5 mn
Last Funding:
USD 4.5 mn (Seed; Dec 2024)
Last valuation:
-
Key competitors
Filter by the segments to which the disruptor belongs
All Segmentsexpand
 
Loading...
Loading...
Loading...
Loading...
Product Overview
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Product Metrics
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Company profile
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Funding data are powered by Crunchbase
arrow
menuarrow
Click here to learn more
Get a demo

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.